Chinese Nuclear Society Expert Delegation Visits Lanzhou Heavy Ion Hospital for Investigation and Gu

Chinese Nuclear Society Expert Delegation Visits Lanzhou Heavy Ion Hospital for Investigation and Guidance

On September 18, an expert delegation from the Chinese Nuclear Society visited Lanzhou Heavy Ion Center for investigation and guidance, engaging in in-depth exchanges on the clinical application and future development of heavy ion therapy technology. This visit marks a new step in the innovative development of China's nuclear technology in the medical field.

The symposium was chaired by Wang Junjie, President of Lanzhou Heavy Ion Center. Vice President Qi Ying provided a detailed introduction to the construction process and clinical operation of the Lanzhou Heavy Ion Center. As China's first carbon ion treatment system with independent intellectual property rights, the center has achieved significant results in the treatment of multiple cancers since its operation, offering new treatment options for cancer patients.

During the meeting, both sides held in-depth discussions on topics such as the standardization of heavy ion therapy technology, talent training mechanisms, and scientific research collaboration models. Wang Shoujun, Chairman of the Chinese Nuclear Society, and Wang Yishen, Vice President of the Applied Technology Research Institute of the Chinese Nuclear Society, highly praised the achievements of the center. They stated that the Nuclear Society would continue to support the research, development, application, and promotion of heavy ion therapy technology.

Lanzhou Heavy Ion Hospital, as a major national science and technology infrastructure, represents the advanced level of China's nuclear technology application in the medical field. This investigation and exchange activity not only demonstrated the center's technical strength but also injected new momentum into promoting the standardization and industrialization of heavy ion therapy technology in China.

Through this high-level exchange, the Lanzhou Heavy Ion Center will further consolidate its leading position in the field of particle therapy both domestically and internationally, contributing to the advancement of Healthy China initiatives and the well-being of the people.

A Glimpse of the Visit

Lanzhou Heavy Ion Center

Gansu Wuwei Cancer Hospital is a state-owned public Class A Grade Three tumor specialist hospital. The Lanzhou Heavy Ion Center is the second heavy ion clinical application center in China with independent intellectual property rights, operated by Gansu Wuwei Cancer Hospital. In collaboration with the first Chinese heavy ion treatment system, the second Chinese heavy ion tumor treatment system was put into clinical operation at the Lanzhou Heavy Ion Center on November 15, 2024. As of now, the center has completed photon and heavy ion treatment for over 300 patients, covering diseases such as lung cancer, pancreatic cancer, liver cancer, and brain glioma.

The Lanzhou Heavy Ion Center has established an elite talent system, bringing together top industry authorities. It features expert workstations led by 50 renowned figures, including Professor Shen Wenjiang, Lifetime Honorary Professor of the Department of Radiation Oncology at Peking University Health Science Center, and Professor Xu Bo, Standing Committee Member of the Chinese Medical Association's Radiation Oncology Branch. Professor Wang Junjie, Chairman of the Chinese Medical Association's Radiation Oncology Branch, serves as the president, providing strong technical support for heavy ion treatment.

Meanwhile, the hospital campus is equipped with a series of cutting-edge medical devices, including Varian's VitalBeam medical linear accelerator, Elekta's Infinity four-dimensional image-guided linear accelerator, 3.0T simulation positioning MRI, GE's 256-slice high-end CT, and Varian's imported iridium-192 afterloader. These hardware facilities form a solid foundation for heavy ion treatment, ensuring efficiency and precision throughout the process.

Aiming to build a comprehensive, full-lifecycle cancer treatment system, the hospital has established departments such as Radiotherapy, Medical Oncology/Hematology, Surgical Oncology, Integrated Traditional Chinese and Western Medicine for Cancer Rehabilitation, Critical Care Medicine, Digestive Endoscopy Center, Imaging, Laboratory Medicine, Ultrasound Medicine, Blood Bank, and Hematology Center Laboratory. It offers comprehensive treatments including photon radiotherapy, chemotherapy, heavy ion therapy, internal medicine, and surgical oncology, as well as services such as imaging, laboratory testing, ultrasound, and bone marrow cell morphology examinations.

Preliminary Review: Zhang Lihong

Final Review: Zhang Jie